dipyridamole has been researched along with leukotriene b4 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colli, S; Tremoli, E | 1 |
Arnout, J; Gresele, P; Vermylen, J | 1 |
Borgeat, P; Krump, E; Lemay, G | 1 |
Humphrey, J; Mullan, M; Paris, D; Parker, T; Town, T | 1 |
4 other study(ies) available for dipyridamole and leukotriene b4
Article | Year |
---|---|
Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes: adenosine-dependent and adenosine-independent mechanisms.
Topics: Adenosine; Blood Coagulation; Dipyridamole; Humans; Leukocytes, Mononuclear; Leukotriene B4; Neutrophils; SRS-A; Superoxides | 1991 |
Dipyridamole inhibits leukotriene B4 synthesis.
Topics: Dipyridamole; Humans; Leukotriene B4 | 1987 |
Adenosine A2 receptor-induced inhibition of leukotriene B4 synthesis in whole blood ex vivo.
Topics: Adenosine; Cardiovascular Agents; Dipyridamole; Humans; Leukotriene B4; Lipopolysaccharides; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Aggregation Inhibitors; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Tumor Necrosis Factor-alpha | 1996 |
beta-Amyloid vasoactivity and proinflammation in microglia can be blocked by cGMP-elevating agents.
Topics: Amyloid beta-Peptides; Animals; Aorta; Cyclic GMP; Dipyridamole; Endothelin-1; In Vitro Techniques; Inflammation; Leukotriene B4; Microglia; Muscle, Smooth, Vascular; Nitroprusside; Peptide Fragments; Rats; Vasoconstriction | 2000 |